INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,861,610 | -41.5% | 90,500 | -24.6% | 0.04% | -48.8% |
| Q2 2023 | $4,893,600 | +9.4% | 120,000 | 0.0% | 0.09% | 0.0% |
| Q1 2023 | $4,472,400 | +36.3% | 120,000 | +27.6% | 0.09% | +65.4% |
| Q4 2022 | $3,281,405 | -70.8% | 94,050 | -53.2% | 0.05% | -66.7% |
| Q3 2022 | $11,252,000 | +65.7% | 201,106 | +53.3% | 0.16% | +66.0% |
| Q2 2022 | $6,790,000 | -69.9% | 131,180 | -57.8% | 0.09% | -65.3% |
| Q1 2022 | $22,577,000 | +386.0% | 310,700 | +690.9% | 0.27% | +421.2% |
| Q4 2021 | $4,645,000 | -70.5% | 39,286 | -66.6% | 0.05% | -71.1% |
| Q3 2021 | $15,763,000 | -89.7% | 117,500 | -87.5% | 0.18% | -91.0% |
| Q2 2021 | $152,699,000 | +360.7% | 943,100 | +128.4% | 1.99% | +179.9% |
| Q1 2021 | $33,143,000 | +509.1% | 413,001 | +313.0% | 0.71% | +474.2% |
| Q4 2020 | $5,441,000 | – | 100,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |